✦ LIBER ✦

Serum YKL-40 following resection for cerebral glioblastoma

✍ Scribed by Daniela Bernardi; Andrea Padoan; Andrea Ballin; MariaTeresa Sartori; Renzo Manara; Renato Scienza; Mario Plebani; Alessandro Della Puppa

Book ID: 106482052
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 264 KB
Volume: 107
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-011-0762-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High serum YKL-40 level after surgery fo

High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival

✍ Christina Cintin; Julia S. Johansen; Ib Jarle Christensen; Paul A. Price; Steen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract ## BACKGROUND YKL‐40 is a member of family 18 glycosyl hydrolases. YKL‐40 is a growth factor and may stimulate migration of endothelial cells. YKL‐40 may also play a role in inflammation and degradation of connective tissue. Elevated preoperative serum YKL‐40 levels in patients with co

YKL-40 and MMP-9 as serum markers for pa

YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma

✍ Andreas F. Hottinger; Fabio M. Iwamoto; Sasan Karimi; Elyn Riedel; Jocelynn Dant 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Objective: To evaluate YKL‐40 and MMP‐9 proteins as tumor biomarkers in serum samples from patients with primary central nervous system lymphoma (PCNSL). ## Methods: In this prospective longitudinal study, serum samples from consecutive patients with histologically confirmed PCNSL

Elevated serum level of YKL-40 is an ind

Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma

✍ Henrik Schmidt; Julia Sidenius Johansen; Julie Gehl; Poul F. Geertsen; Kirsten F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

Elevated pretreatment serum concentratio

Elevated pretreatment serum concentration of YKL-40—An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer

✍ Ina Thöm; Birte Andritzky; Gunter Schuch; Iris Burkholder; Lutz Edler; Julia S. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

Erratum: Schmidt H, Johansen JS, Gehl J,

Erratum: Schmidt H, Johansen JS, Gehl J, et al. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer. 2006;106(5):1130–9.

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views